Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

February 1, 2012

Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Free full text available in HTML and PDF formats.
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
Diabetic retinopathy in the SEARCH for Diabetes in Youth Cohort: a pilot study.
Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus.
Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring.
Proinsulin C-peptide interferes with insulin fibril formation.

January 25, 2012

Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years.
Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes.
A novel strategy for long-term implantable artificial pancreas.

January 18, 2012

Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia.
Closed-loop glucose control: psychological and behavioral considerations.
Continuous glucose monitoring considerations for the development of a closed-loop artificial pancreas system.
A controlled study of the effectiveness of an adaptive closed-loop algorithm to minimize corticosteroid-induced stress hyperglycemia in type 1 diabetes.
Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the cambridge cohort.
Neighborhood level risk factors for type 1 diabetes in youth: the SEARCH case-control study.
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.
Left ventricular filling patterns and its relation to left ventricular untwist in patients with type 1 diabetes and normal ejection fraction.
The Timing of Dialysis and Kidney Transplantation in Type 1 Diabetes.

January 11, 2012

Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. Free full text available in PDF format. See also Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes and Type 1 Diabetes Reversed With Stem Cells From Cord Blood.
Characterization of a Novel Functional Protein in the Pancreatic Islet: Islet Homeostasis Protein Regulation of Glucagon Synthesis in alpha Cells. See also Researchers Discover Protein that May Represent New Target for Treating Type 1 Diabetes.
Promoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetes. Free full text available in HTML and PDF formats.
25-Hydroxyvitamin D Concentrations and In Vivo Insulin Sensitivity and beta-Cell Function Relative to Insulin Sensitivity in Black and White Youth.
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.
Blue Flash ERG PhNR Changes Associated with Poor Long-Term Glycemic Control in Adolescents with Type 1 Diabetes.

January 4, 2012

Towards an artificial pancreas at home.
Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
Regulated and Reversible Induction of Adult Human beta-Cell Replication.
Latent Autoimmune Diabetes of Adults Is Phenotypically Similar to Type 1 Diabetes in a Minority Population.

December 28, 2011

How does age at onset influence the outcome of autoimmune diseases? Free full text available in HTML and PDF formats.
Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients.
Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation.

December 21, 2011

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes. Free full text available in HTML and PDF formats.
Striated muscle as implantation site for transplanted pancreatic islets. Free full text available in HTML and PDF formats.
Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes.
The D-Lightful Vitamin D for Child Health.

December 14, 2011

Increase in the incidence of type 1 diabetes in Israeli children following the Second Lebanon War.
Update from the Faustman Lab: Moving Forwrd to Phase 2.

December 7, 2011

FDA outlines flexible approaches for artificial pancreas system clinical trials, product approvals See also JDRF Encouraged By Draft FDA Artificial Pancreas Guidance and FDA Issues Artificial Pancreas Guidance Document.
Intravital imaging of CTLs killing islet cells in diabetic mice. See also a Jolla Institute researchers provide world’s first view of Type 1 diabetes as it unfolds.
Type 1 diabetes in Cheshire: Cardiometabolic risk factor trends (2004-2009).
End-stage nephropathy in Type 1-diabetes mellitus – Kidney transplantation alone or combined with Islet or pancreas transplantation?
Improved Postprandial Glycemic Control in Patients with Type 2 Diabetes from Subcutaneous Injection of Insulin Lispro with Hyaluronidase.
Reversal of diabetes by the creation of neo-islet tissues into a subcutaneous site using islet cell sheets.

November 30, 2011

Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring.
Impaired diffusing capacity for carbon monoxide in children with type 1 diabetes: is this the first sign of long-term complications?
Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
Case report: type 1 diabetes in monozygotic quadruplets.

« Previous
1
…
56
57
58
59
60
…
94
Next »

advertisement

Last Updated: Monday, June 16, 2025 18:42:42 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Email
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.